S. Wahler

780 total citations
21 papers, 303 citations indexed

About

S. Wahler is a scholar working on Epidemiology, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, S. Wahler has authored 21 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Economics and Econometrics and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in S. Wahler's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Trace Elements in Health (3 papers) and Diabetic Foot Ulcer Assessment and Management (2 papers). S. Wahler is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Trace Elements in Health (3 papers) and Diabetic Foot Ulcer Assessment and Management (2 papers). S. Wahler collaborates with scholars based in Germany, Switzerland and Austria. S. Wahler's co-authors include J.-Matthias Graf von der Schulenburg, F Jost, Reiner Leidl, Jürgen Wasem, T Volmer, Maria Kubin, Thomas Mittendorf, Andreas Tiede, Christian Weber and Christoph Vauth and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Environmental Research and Public Health and Value in Health.

In The Last Decade

S. Wahler

18 papers receiving 287 citations

Peers

S. Wahler

EPIDE

GHP

CCM

PHEOH

K H Leong Singapore

Oliver Schoeffski Germany

B. Curtis United States

Laura Weber United States

Winnie Magadi United Kingdom

Jonathan Witonsky United States

Sofia Löfvendahl Sweden

Ehizogie Edigin United States

Maryam Nasserinejad Iran

Korinna Karampampa Sweden

K H Leong Singapore

S. Wahler

64 ×0.9

62 ×1.1

EPIDE

47 ×1.0

GHP

35 ×0.9

CCM

33 ×1.0

PHEOH

Citations per year, relative to S. Wahler S. Wahler (= 1×) peers K H Leong

Countries citing papers authored by S. Wahler

Since Specialization

Citations

This map shows the geographic impact of S. Wahler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Wahler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Wahler more than expected).

Fields of papers citing papers by S. Wahler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Wahler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Wahler. The network helps show where S. Wahler may publish in the future.

Co-authorship network of co-authors of S. Wahler

This figure shows the co-authorship network connecting the top 25 collaborators of S. Wahler. A scholar is included among the top collaborators of S. Wahler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Wahler. S. Wahler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schreiber, Stefan, Lutz von Müller, Hans–Jörg Epple, et al.. (2023). Trends in the epidemiology of Clostridioides difficile infection in Germany. Infection. 51(6). 1695–1702. 7 indexed citations

Stallmach, Andreas, Lutz von Müller, Martin Storr, et al.. (2023). Fäkaler Mikrobiota-Transfer (FMT) in Deutschland – Status und Perspektive. Zeitschrift für Gastroenterologie. 62(4). 490–499. 4 indexed citations

Wahler, S., et al.. (2022). Cost-effectiveness of a photopethysmographic procedure for screening for atrial fibrillation in 6 European countries. Health Economics Review. 12(1). 17–17. 7 indexed citations

Wahler, S., et al.. (2022). Adjuvant treatment of high-risk melanoma – cost-effectiveness analysis of treatment options for BRAF 600 mutated tumors. Health Economics Review. 12(1). 8–8. 3 indexed citations

Kurzweil, Peter, Alfred Müller, & S. Wahler. (2021). The Ecological Footprint of COVID-19 mRNA Vaccines: Estimating Greenhouse Gas Emissions in Germany. International Journal of Environmental Research and Public Health. 18(14). 7425–7425. 23 indexed citations

Birkemeyer, Ralf, et al.. (2020). A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany. Health Economics Review. 10(1). 16–16. 13 indexed citations

Wahler, S., et al.. (2020). PRO58 Hospitalization Frequency of Membranoproliferative Glomerulonephritis in Germany. Value in Health. 23. S700–S700. 1 indexed citations

Wahler, S., et al.. (2020). Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany. SHILAP Revista de lepidopterología. 9(1). 1861804–1861804. 4 indexed citations

Wahler, S. & Karl-Heinz Weiss. (2020). PGI20 Prevelance and Treatment of Wilson Disease in Germany. Value in Health. 23. S536–S536. 1 indexed citations

10.

Tiede, Andreas & S. Wahler. (2020). The rising incidence of acquired haemophilia A in Germany. Haemophilia. 27(4). e466–e468. 22 indexed citations

11.

Wahler, S., et al.. (2019). PDB72 DEPRIVATION - MAIN CAUSE OF DIABETIC FOOT ULCER IN GERMANY. Value in Health. 22. S586–S586. 1 indexed citations

12.

Wahler, S., et al.. (2019). PDB77 WILSON'S DISEASE: COST OF HOSPITALIZATION IN GERMANY. Value in Health. 22. S587–S587. 1 indexed citations

13.

Wahler, S.. (2018). DGK Herztage 2018 / Annual Meeting vom 11. - 13. Oktober 2018 in Berlin. Clinical Research in Cardiology. 107(S3). 1–1.

14.

Wahler, S., et al.. (2017). Cost-Effectiveness Comparison Between Biobrane and Suprathel for Partial Thickness Burn Treatment for Austria. Value in Health. 20(9). A802–A802.

15.

Wahler, S. & Andreas Tiede. (2017). Trend In Hospital Cases of Acquired Hemophilia A (AHA) 2010-2015 In Germany. Value in Health. 20(9). A566–A566. 2 indexed citations

16.

Winther, Simon, Morten Bøttcher, S. Wahler, & Kristian Bolin. (2017). Cost Model for a New Acoustic Diagnostic AID to Rule Out Coronary Artery Disease. Value in Health. 20(9). A405–A405. 1 indexed citations

17.

Birkemeyer, Ralf, A. Müller, Henrik Schneider, et al.. (2013). Short term cost effectiveness of a regional myocardial infarction network. Health Economics Review. 3(1). 10–10. 4 indexed citations

18.

Schulenburg, J. - Matthias Graf von der, Wolfgang Greiner, F Jost, et al.. (2008). German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus. Value in Health. 11(4). 539–544. 135 indexed citations

19.

Schulenburg, J. - Matthias Graf von der, F Jost, Maria Kubin, et al.. (2007). Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation - dritte und aktualisierte Fassung des Hannoveraner Konsens. Gesundheitsökonomie & Qualitätsmanagement. 12(5). 285–290. 67 indexed citations

20.

Birkeland, K. I., et al.. (1995). BONE MASS IN NONINSULIN - DEPENDENT DIABETES MELLITUS. 55(3). 257–262. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact